CD276 and cancer: Our analysis revealed that elevated PLEK2 expression was significantly associated with increased expression of several key immune checkpoint molecules, such as CD276 (B7-H3), CD274 (PD-L1), LGALS9, PVR (CD155), and FAS across a wide spectrum of cancers (Fig. 5c).